Human il-4 muteins in cancer therapy

Details Human il-4 muteins in cancer therapy Human il-4 muteins in cancer therapy

A - Human Necessities

61

K

A61K 38/20 (2006.01) A61K 45/06 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2656135

The present invention relates to the use of a combination of human interleukin-4 muteins and chemotherapeutic or pro-apoptotic agents for the prevention and/or treatment of cancer disease.

La présente invention concerne l'utilisation d'une combinaison de mutéines d'interleukine-4 humaines et d'agents chimiothérapeutiques ou pro-apoptotiques pour la prévention et/ou le traitement d'une maladie cancéreuse.

Affiliated with

Also associated with

Rating

Human il-4 muteins in cancer therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human il-4 muteins in cancer therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human il-4 muteins in cancer therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2079334